Bausch Health Companies | VRX - 应收帐款人





应收帐款人 更改 日
Amgen USD 9.14B 432M 2026-03
ANI Pharmaceuticals USD 255.43M 25.65M 2026-03
Aurora Cannabis CAD 44.58M 3.68M 2026-03
Bausch Health Companies USD 2.19B 160M 2026-03
Biogen USD 1.79B 76.6M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Canopy Growth CAD 36.29M 104.13M 2026-03
Corcept Therapeutics USD 39.07M 20.71M 2026-03
Danaher USD 4.76B 845M 2026-03
Drreddys Laboratories INR 123.17B 121.76B 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novo Nordisk DKK 106.26B 11.21B 2026-03
Pacira USD 125.64M 1.57M 2026-03
Perrigo USD 697.1M 84.3M 2026-03
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 191.92M 1.46M 2026-03
Supernus Pharmaceuticals USD 182.18M 5.62M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Zoetis USD 1.51B 84M 2026-03